In this proposal I will study the molecular mechanism of action of the prototype selective androgen receptor modulators (SARMs) we have identified. These androgen receptor ligands are unique because they appear to induce conformational changes in androgen receptor which are different from those induced by full agonists. My preliminary data indicates that these compounds show promoter specificities different from that of full agonists, which allows looking at them as candidate selective androgen receptor modulators - SARMs. To characterize the mechanism of action of these compounds, will first establish the gene expression patterns attributable to each compound, focusing on the two relatively well established arenas of androgen action: prostate epithelium proliferation and regulation of fat and cholesterol metabolism. I will then move to identify the protein-protein interaction surfaces exposed on AR when liganded with each of these compounds. Finally, I will establish the link between exposed surfaces on AR and ligand-specific transcriptional regulation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32DK067734-02
Application #
6895437
Study Section
Special Emphasis Panel (ZRG1-F06 (20))
Program Officer
Hyde, James F
Project Start
2004-06-01
Project End
2007-05-31
Budget Start
2005-06-01
Budget End
2006-05-31
Support Year
2
Fiscal Year
2005
Total Cost
$49,928
Indirect Cost
Name
Duke University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705